NASDAQ:FBRC

(FBRC) Stock Forecast, Price & News

$17.55
0.00 (0.00 %)
(As of 06/12/2017)
Add
Compare
Today's Range
$17.55
▼
$17.55
50-Day Range
$17.55
▼
$17.55
52-Week Range
$10.57
▼
$19.53
VolumeN/A
Average Volume59,103 shs
Market Capitalization$124.61 million
P/E RatioN/A
Dividend Yield4.52%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive FBRC News and Ratings via Email

Sign-up to receive the latest news and ratings for (FBRC) and its competitors with MarketBeat's FREE daily newsletter.


(FBRC) logo

About (FBRC)

FBR & Co. is an investment banking and institutional brokerage company. The Company focuses on the equity capital markets. The Company operates through two segments: capital markets, which includes investment banking, institutional brokerage and research, and principal investing. Through its broker-dealer operating subsidiaries, the Company focuses its business on providing: capital raising services, including underwriting and placement of public and private equity, equity-linked and debt securities; financial advisory services, including merger and acquisition (M&A) advisory, restructuring, liability management, recapitalization and strategic alternative analysis; institutional sales and trading services focused on equities, equity-linked securities, listed options, high-yield bonds, senior debt and bank loans, as well as securities lending activities, and differentiated securities research.

Headlines

Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
Checkpoint Therapeutics to Present at Virtual Corporate Access Summit Hosted by B. Riley FBR on Wednesday, August 19, 2020
August 17, 2020 |  feeds.benzinga.com
These Bay Area hospitals made the 2020 U.S. News & World Report national rankings
These Bay Area hospitals made the 2020 U.S. News & World Report national rankings
July 29, 2020 |  feeds.bizjournals.com
Falling Earnings Estimates Signal Weakness Ahead for FBR & Co
Falling Earnings Estimates Signal Weakness Ahead for FBR & Co
July 23, 2020 |  sg.finance.yahoo.com
MediciNova to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit
MediciNova to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit
July 20, 2020 |  www.benzinga.com
B. Riley FBR boosts Fannie, Freddie on Supreme Court cash sweep review
B. Riley FBR boosts Fannie, Freddie on Supreme Court cash sweep review
July 13, 2020 |  seekingalpha.com
Deep Dive: 20 technology stocks with low debt to consider owning in a down market
Deep Dive: 20 technology stocks with low debt to consider owning in a down market
April 3, 2020 |  www.marketwatch.com
Hopes for a deal dim as U.S.-China trade talks get underway in tense atmosphere
Hopes for a deal dim as U.S.-China trade talks get underway in tense atmosphere
October 7, 2019 |  feeds.reuters.com
Build-A-Bear Workshop (BBW) Presents At B. Riley FBR Consumer & Media Conference - Slideshow
Build-A-Bear Workshop (BBW) Presents At B. Riley FBR Consumer & Media Conference - Slideshow
October 4, 2019 |  seekingalpha.com
Cadiz to Present at B. Riley FBR Consumer & Media Conference
Cadiz to Present at B. Riley FBR Consumer & Media Conference
October 3, 2019 |  feeds.benzinga.com
ChromaDex to Present at the 5th Annual B. Riley FBR Consumer and Media Conference
ChromaDex to Present at the 5th Annual B. Riley FBR Consumer and Media Conference
September 26, 2019 |  www.benzinga.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank™

Overall MarketRank™

1.27 out of 5 stars

Manufacturing Sector

5th out of 113 stocks

Electronic Computer Manufacturing Industry

4th out of 101 stocks

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











(FBRC) (NASDAQ:FBRC) Frequently Asked Questions

What stocks does MarketBeat like better than (FBRC)?

Wall Street analysts have given (FBRC) a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but (FBRC) wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were (FBRC)'s earnings last quarter?

(FBRC) (NASDAQ:FBRC) posted its earnings results on Thursday, July, 14th. The financial services provider reported ($1.08) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.11 by $1.19. The financial services provider earned $20.89 million during the quarter, compared to analyst estimates of $35.82 million.
View (FBRC)'s earnings history.

How has (FBRC)'s stock been impacted by COVID-19?

(FBRC)'s stock was trading at $17.55 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, FBRC stock has increased by 0.0% and is now trading at $17.55.
View which stocks have been most impacted by COVID-19.

Is (FBRC) a good dividend stock?

(FBRC) pays an annual dividend of $0.80 per share and currently has a dividend yield of 4.52%. FBRC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View (FBRC)'s dividend history.

Who are (FBRC)'s key executives?

(FBRC)'s management team includes the following people:
  • Richard J. Hendrix, Chairman of the Board, President, Chief Executive Officer
  • Bradley J. Wright, Chief Financial Officer, Executive Vice President, Chief Administrative Officer
  • Adam J. Fishman, Executive Vice President, Head - Sales and Research
  • Michael A. Lloyd, Executive Vice President, Head - Trading
  • Kenneth P. Slosser, Executive Vice President, Head - Investment Banking
  • Robert J. Kiernan, Senior Vice President, Chief Accounting Officer, Controller
  • Rahul R. Jasuja Ph.D., Senior Vice President
  • , Bio & Compensation - 
  • Arthur J. Reimers, Lead Independent Director
  • Mark Robert Patterson, Director
  • William F. Strome J.D., Director

Who are some of (FBRC)'s key competitors?

Some companies that are related to (FBRC) include Morgan Stanley (MS), The Goldman Sachs Group (GS), The Charles Schwab (SCHW), Raymond James (RJF), LPL Financial (LPLA), Stifel Financial (SF), Evercore (EVR), Lazard (LAZ), BGC Partners (BGCP), Piper Jaffray Companies (PJC), Cowen (COWN), Oppenheimer (OPY), Greenhill & Co., Inc. (GHL) and Global Brokerage (GLBR).
View all of FBRC's competitors.

What other stocks do shareholders of (FBRC) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (FBRC) investors own include Ritter Pharmaceuticals (RTTR), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Aphria (APHQF), Bellerophon Therapeutics (BLPH), Peabody Energy (BTUUQ), Halliburton (HAL), KKR & Co. Inc. (KKR), Revolution Lighting Technologies (RVLT) and Fang (SFUN).

What is (FBRC)'s stock symbol?

(FBRC) trades on the NASDAQ under the ticker symbol "FBRC."

How do I buy shares of (FBRC)?

Shares of FBRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is (FBRC)'s stock price today?

One share of FBRC stock can currently be purchased for approximately $17.55.

How much money does (FBRC) make?

(FBRC) has a market capitalization of $124.61 million.

How many employees does (FBRC) have?

(FBRC) employs 147,000 workers across the globe.

What is (FBRC)'s official website?

The official website for (FBRC) is www.fbr.com.

Where are (FBRC)'s headquarters?

(FBRC) is headquartered at 1300 17th St N Ste 1400, ARLINGTON, VA 22209-3807, United States.

How can I contact (FBRC)?

(FBRC)'s mailing address is 1300 17th St N Ste 1400, ARLINGTON, VA 22209-3807, United States. The financial services provider can be reached via phone at +1-703-3129500.


This page was last updated on 7/31/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.